Literature DB >> 1923503

Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer.

W P Bennett1, M C Hollstein, A He, S M Zhu, J H Resau, B F Trump, R A Metcalf, J A Welsh, C Midgley, D P Lane.   

Abstract

A strategy and methods for archival analysis of genetic and protein alterations in the p53 tumor-suppressor gene are presented. The tumor series includes 43 paraffin-embedded esophageal carcinomas from two high-incidence regions in the People's Republic of China. More than half contained elevated p53 protein levels which were detected by a high-titer polyclonal antiserum and a sensitive immunohistochemical method. To estimate the frequency of underlying mutations, DNA was isolated from conventional paraffin sections, amplified by the polymerase chain reaction, and examined by dideoxy termination sequencing. Analysis of exons 5-8 in a subset of 10 tumors revealed mis-sense point mutations in 4 out of 5 immunostain-positive tumors and a mutation encoding a stop codon in 1 of 5 immunostain-negative tumors. In this report of archival material, we conclude that detectable levels of p53 protein correlate closely with the occurrence of mis-sense mutations. Furthermore, these methods render large repositories of paraffin-embedded tumor and non-tumor tissues accessible to analysis. Immunohistochemical screening for elevated protein levels followed by sequence analysis represents an efficient strategy for the evaluation of the p53 mutational spectrum.

Entities:  

Mesh:

Year:  1991        PMID: 1923503

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts.

Authors:  G R Ogden; D M Chisholm; R A Kiddie; D P Lane
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

2.  p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.

Authors:  A G Casson; M Tammemagi; S Eskandarian; M Redston; J McLaughlin; H Ozcelik
Journal:  Mol Pathol       Date:  1998-04

3.  Expression of p53 product in Chinese human bladder carcinoma.

Authors:  D W Ye; J F Zheng; S X Qian; Y J Ma
Journal:  Urol Res       Date:  1993-05

4.  Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid.

Authors:  N Hayashi; M Furihata; Y Ohtsuki; H Ueno
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Expression of p53 protein related to human papillomavirus and DNA ploidy in superficial esophageal carcinoma.

Authors:  T Nakamura; H Ide; R Eguchi; K Hayashi; F Hanyu; K Nagasako; M Yukawa; K Asaka; T Fujimori; S Maeda
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 6.  Multimodality treatment of cancer arising from Barrett's epithelium.

Authors:  J A Roth
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

7.  p53 alterations in human squamous cell carcinomas and carcinoma cell lines.

Authors:  J Caamano; S Y Zhang; E A Rosvold; B Bauer; A J Klein-Szanto
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

8.  Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.

Authors:  M Akasofu; Y Oda
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Expressions of PCNA, p53, p21(WAF-1) and cell proliferation in fetal esophageal epithelia: comparative study with adult esophageal lesions from subjects at high-incidence area for esophageal cancer in Henan, North China.

Authors:  Ying Xing; Yu Ning; Li-Qiang Ru; Li-Dong Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  Immunohistochemical analysis of p53 expression in anal squamous neoplasia.

Authors:  O A Ogunbiyi; J H Scholefield; J H Smith; S V Polacarz; K Rogers; F Sharp
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.